The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE

Authors
Ho-Young YhimMoon Ju JangJae-Yong KwakChang-Yeol YimWon-Il ChoiYong Cheol LeeJeong-Ok LeeKeun-Wook LeeSoo-Mee BangSung-Hyun KimYeo-Kyeoung KimHye Jung ChangDoyeun Ohthe Korean Venous Thromboembolism Working Party
Department
Dept. of Internal Medicine (내과학); Dept. of Anesthesiology & Pain Medicine (마취통증의학)
Issue Date
2013
Citation
Thrombosis Research, Vol.131(4) : e133-e140, 2013
ISSN
0049-3848
Abstract
Patients with cancer have been associated with increased risk of recurrent venous thromboembolism (VTE). However, data on recurrent VTE in Asian patients with advanced solid cancers are limited. Methods This study was conducted using data from the Korean VTE registry, which is an ongoing, prospective database. Patients were eligible if they had diagnosed with recurrent/metastatic solid cancers and initiated anticoagulation therapy following index VTE diagnosis. A total of 449 patients were included in this analysis. The 6-month and 12-month cumulative incidences of recurrent VTE were 20.6% and 27.0%, respectively. Isolated pulmonary embolism (PE) (51%) was the most predominant recurrence type. Pancreas as the primary tumor site, poor Eastern Cooperative Oncology Group performance status at the time of index VTE diagnosis, and initial presentation with PE were independent risk factors for developing recurrent VTE. With a median follow-up of 29.1 months (range, 1.0-91.2), the median overall survival (OS) was 11.9 months. Patients with recurrent VTE had a significantly worse OS than those without recurrent VTE (median, 8.4 vs. 13.0 months, respectively; P = 0.001). In conclusion, the incidence of recurrent VTE in Korean patients with advanced solid cancers is comparable with Caucasian patients. Pancreas as the primary tumor site, poor performance status, and initial presentation with PE are independent recurrent VTE risk factors in advanced cancer VTE patients. Additionally, OS is adversely affected by recurrent VTE. Keywords Venous thromboembolism; Deep vein thrombosis; Cancer; Recurrence; Survival
Keywords
Venous thromboembolismDeep vein thrombosisCancerRecurrenceSurvival
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/34653
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Anesthesiology & Pain Medicine (마취통증의학)
Keimyung Author(s)
최원일; 이용철
Full Text
https://www.sciencedirect.com/science/article/pii/S0049384813000303?via%3Dihub
File in this Item
 사서에게 요청하기
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE